Duncan Jarvies

But also working for Apple.

Carl's just going for the dark side.

If we think back to the harms podcast that you did, a little callback there, there were a number of things there, though, about, you know, the roles of regulators in doing stuff and sort of ghost management, the stage management of getting a new drug or device on the market.

Do you think that just focusing on education is actually enough when it's the whole system that, you know, is open to these conflicts of interest?

It does feel like this is coming at the right time, I suppose.

More and more people are aware of that and I think just a broader conversation in society around the kind of influence of companies.

Well, there you go.

If you want to do that work or any other work, write up about the things that you're doing.

Then I'll put the link in the podcast text for people to go and do that.

So we have come to the point in the podcast where we usually have, we give Carl Free Reign to go and tell us what's on his mind.

But he's been doing that all year.

And in fact, even in this podcast, we can't stop him.

So this time we are going to hand the mantle over to Helen.

And what's got you fired up this week in the Christmas BMJ?

Well, what it means is like a big data.

Yeah.

I think this is particularly interesting when you also read that alongside one of our colleagues' articles this year, which says it's time's up for he and him as the default pronouns for doctors, which is essentially making the point that the profession has changed to be more women involved.

The medical students all coming through are predominantly women, though, so there must be a lump of...

Old men who are kind of going out of the top of their professions.

Absolutely.